Related references
Note: Only part of the references are listed.Prerequisite OCT4 Maintenance Potentiates the Neural Induction of Differentiating Human Embryonic Stem Cells and Induced Pluripotent Stem Cells
Sheng-Mei Chen et al.
CELL TRANSPLANTATION (2015)
Synaptic dysregulation in a human iPS cell model of mental disorders
Zhexing Wen et al.
NATURE (2014)
n-Butylidenephthalide Protects against Dopaminergic Neuron Degeneration and α-Synuclein Accumulation in Caenorhabditis elegans Models of Parkinson's Disease
Ru-Huei Fu et al.
PLOS ONE (2014)
Wnt signaling in the nervous system and in Alzheimers disease
Nibaldo C. Inestrosa et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2014)
Modeling Alzheimer's Disease with iPSCs Reveals Stress Phenotypes Associated with Intracellular Aβ and Differential Drug Responsiveness
Takayuki Kondo et al.
CELL STEM CELL (2013)
Modeling neurogenesis impairment in down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells
Huai-En Lu et al.
EXPERIMENTAL CELL RESEARCH (2013)
Deficits in human trisomy 21 iPSCs and neurons
Jason P. Weick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
DL-3-n-Butylphthalide, an Anti-Oxidant Agent, Prevents Neurological Deficits and Cerebral Injury Following Stroke per Functional Analysis, Magnetic Resonance Imaging and Histological Assessment
Lihong Zhang et al.
CURRENT NEUROVASCULAR RESEARCH (2012)
Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture
Anna L. Lahti et al.
DISEASE MODELS & MECHANISMS (2012)
Expression of Nur77 induced by an n-butylidenephthalide derivative promotes apoptosis and inhibits cell growth in oral squamous cell carcinoma
Po Yen Liu et al.
INVESTIGATIONAL NEW DRUGS (2012)
Dl-3-n-butylphthalide, a natural antioxidant, protects dopamine neurons in rotenone models for Parkinson's disease
Nian Xiong et al.
NEUROBIOLOGY OF AGING (2012)
L-3-n-butylphthalide improves cognitive deficits in rats with chronic cerebral ischemia
Jing Xu et al.
NEUROPHARMACOLOGY (2012)
Induction of Apoptosis Coupled to Endoplasmic Reticulum Stress in Human Prostate Cancer Cells by n-butylidenephthalide
Sheng-Chun Chiu et al.
PLOS ONE (2012)
L-3-n-Butylphthalide regulates amyloid precursor protein processing by PKC and MAPK pathways in SK-N-SH cells over-expressing wild type human APP695
Ying Peng et al.
NEUROSCIENCE LETTERS (2011)
Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
Naoki Yahata et al.
PLOS ONE (2011)
A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells
Maria C. N. Marchetto et al.
CELL (2010)
Multifunctional doxorubicin/superparamagnetic iron oxide-encapsulated Pluronic F127 micelles used for chemotherapy/magnetic resonance imaging
Jian-Ren Lai et al.
JOURNAL OF APPLIED PHYSICS (2010)
Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease
Maria Cristina Rosi et al.
JOURNAL OF NEUROCHEMISTRY (2010)
L-3-n-Butylphthalide Improves Cognitive Impairment and Reduces Amyloid-β in a Transgenic Model of Alzheimer's Disease
Ying Peng et al.
JOURNAL OF NEUROSCIENCE (2010)
n-Butylidenephthalide induced apoptosis in the A549 human lung adenocarcinoma cell line by coupled down-regulation of AP-2 alpha and telomerase activity
Chyou-wei Wei et al.
ACTA PHARMACOLOGICA SINICA (2009)
Down syndrome-recent progress and future prospects
Frances K. Wiseman et al.
HUMAN MOLECULAR GENETICS (2009)
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Stuart M. Chambers et al.
NATURE BIOTECHNOLOGY (2009)
Disease-specific induced pluripotent stem cells
In-Hyun Park et al.
CELL (2008)
Amyloid-β binds to the extracellular cysteine-rich domain of frizzled and inhibits wnt/β-catenin signaling
Margaret H. Magdesian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Blastocoel volume is related to successful establishment of human embryonic stem cell lines
En-Hui Cheng et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2008)
The GSK3 hypothesis of Alzheimer's disease
Claudie Hooper et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
GSK3β activity modifies the localization and function of presenilin 1
Kengo Uemura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
Carlo Ballatore et al.
NATURE REVIEWS NEUROSCIENCE (2007)
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease
Katharina Buerger et al.
BRAIN (2006)
The natural compound n-butylidenephthalide derived from Angelica sinensis inhibits malignant brain tumor growth in vitro and in vivo3
Nu-Man Tsai et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective
RE Tanzi et al.
CELL (2005)
Wnt-3a overcomes β-amyloid toxicity in rat hippocampal neurons
AR Alvarez et al.
EXPERIMENTAL CELL RESEARCH (2004)
Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain
A Caricasole et al.
JOURNAL OF NEUROSCIENCE (2004)
Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory
PR Turner et al.
PROGRESS IN NEUROBIOLOGY (2003)
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain
HF Dovey et al.
JOURNAL OF NEUROCHEMISTRY (2001)
The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bε at Ser539 and the microtubule-associated protein tau at Thr212:: potential role for DYRK as a glycogen synthase kinase 3-priming kinase
YL Woods et al.
BIOCHEMICAL JOURNAL (2001)
Share Paper
